Observational studyMedicina (Kaunas, Lithuania)2025

Improvement of Cardiometabolic Control with Dapagliflozin in Patients with Type 2 Diabetes in Primary Care: The AGORA-AP Study.

Vicente Pallarés-Carratalá et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.